KLOW INJECTOR PEN 3ML

KLOW – Peptide Blend: Ultimate Comprehensive Regenerative & Healing Formula
(10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV + 50 mg GHK-Cu)

KLOW represents one of the most advanced and inclusive multi-peptide research formulations now commercially available. This powerful synergy of four of the most well-documented regenerative and protective peptides provides a single, easy to administer source for researchers wishing to investigate the potential relationships among several interrelated biological pathways that are critical to the process of tissue repair, inflammation regulation, cellular renewal, remodeling of the extracellular matrix, and whole-body recovery.

Research communities have referred to this combination of peptides as an enhanced “Glow Stack”, “Wolverine Blend” or advanced recovery complex. KLOW offers a researcher-friendly, all-in-one platform for studying interconnected mechanisms of healing related to:

•Muscle/skeletal injury models
•Post-surgery recovery models
•Chronic inflammatory models
•Skin regeneration models
•Longevity models

Science behind each of the peptides in KLOW

BPC-157 (Body Protection Compound – 157):
A stable gastric pentadecapeptide derived from a human gastric juice protective protein, BPC-157 exhibits extensive pleotropic healing properties across many preclinical models. As part of its mechanism, BPC-157 up-regulates vascular endothelial growth factor (VEGF) and modulates nitric oxide (NO) pathways. BPC-157 also activates FAK-paxillin and VEGFR2-Akt-eNOS signaling cascades. Additionally, BPC-157 increases growth hormone receptor expression in fibroblasts and tendon cells. Through these mechanisms BPC-157 drives repair in tendons, ligaments, muscles, bones and the gastrointestinal system and limits excessive inflammation and maintains endothelium integrity. In addition to facilitating rapid soft tissue repair, BPC-157 protects against NSAID induced damage and facilitates functional recovery even in difficult injury models.

TB-500:
Synthetic Thymosin Beta-4 (TB-4) fragment, TB-500 is used to facilitate cell migration, cell differentiation and angiogenesis. TB-500 regulates actin polymerization to accelerate wound closure, improve tissue compliance (flexibility), limit scar formation through limiting myofibroblast activation and facilitate repair in muscle, tendon, ligament, cornea and heart. TB-500 increases blood flow to injured sites, enhance stem cell survival, reduce inflammation and accelerate regeneration of cartilage and other poorly vascularized tissues in preclinical models.

KPV:
Anti-inflammatory tripeptide (lys-pro-val) which is derived from the c-terminal sequence of alpha melanocyte stimulating hormone (alpha-mslh). KPV selectively inhibits key inflammatory pathways (NF-kb/MAP kinase) while down-regulating pro-inflammatory cytokines (TNFa, IL-6/IL-1beta) using transport into cells via pepT1. KPV preserves mucosa barrier integrity and immune balance without causing broad immunosuppression. KPV has been shown to be effective in reducing inflammation in models of colitis/inflammatory bowel disease/intestinal inflammation as well as systemic inflammatory conditions and preserve tissue structure while accelerating mucosa repair.

GHK-Cu:
Naturally occurring copper binding tripeptide which decreases with age, GHK-Cu acts as a master regulator of tissue remodeling. GHK-Cu stimulates synthesis of collagen (type I/III/IV), elastin and glycosaminoglycans/decorin and antioxidant defenses; stimulate angiogenesis; and regulate gene expression related to repair and aging. GHK-Cu has been shown to improve skin elasticity/firmness/wound closure/extracellular matrix quality while decreasing oxidative stress and supporting hair follicle health.

Synergy of the full KLOW Blend:

The synergism associated with the three peptides listed above (BPC-157/TB-500/KPV) create a unique complementarity where:

•TB-500/BPC-157 drive deep structural repair and vascularization.
•KPV suppresses excessive inflammation that could impede recovery.
•GHK-CU optimizes collagen quality, long term tissue remodeling and aesthetics.

Preclinical findings based upon similar multi-peptide combinations indicate that the ability to produce simultaneous synergistic results may lead to increased rates of injury recovery time, decreased fibrosis, improved skin/gut barrier function, and overall regenerative efficiency than would be achieved by administering the individual peptides alone. Therefore, KLOW creates a comprehensive “healing environment” capable of addressing the entire continuum of repair processes.

Potential Benefits of Research Supported by Data:

Increased Rates of Musculoskeletal/Skin/GI Tract Recovery Time
TB-500/BPC-157 combination induces rapid tendon-to-bone integration/muscle regeneration/ligament fortification/function recovery. Increased fibroblast activity/organized collagen deposition/better angiogenesis/cell migration contributes to lower recovery times and greater success in traumatic injury/post-surgical/hypovascular tissue injury models. Greater tensile strength/reduced complications observed in poorly vascularized tissues noted.

Effective Anti-Inflammatories /Immune Modulators
Combination of KPV with BPC-157/TB-500 produces selective inhibition of NF-kb/MAP Kinase/Cytokine Pathways. Targeted suppression of local/systemic inflammation in preclinical models of colitis/arthritis/skin diseases/chronic conditions created optimal conditions for repair while maintaining immune surveillance.

Enhanced Skin Rejuvenation/Collagen Remodeling
GHK-CU has been demonstrated to significantly increase collagen production (70%) in certain laboratory models. GHK-CU has been shown to enhance skin elasticity/firmness/barrier function/wound healing. Combination with the regenerative capability of BPC-157/TB-500 provides support for both internal connective tissue repair/dermal restoration resulting in less scarring/more tone/anti-aging.

GI Protection/Intestinal Mucosa Barrier Restoration
Cytoprotection provided by BPC-157 includes healing ulcers/protection from NSAID/alcohol damage/support in IBD model. Support for repairing tight junctions/intestinal inflammation/mucosa healing in IBS/microbial imbalance/digestive resilience models provided by KPV.

Potential for Broad-Spectrum Regeneration/Anti-Aging/Systemic Wellness
Potential uses include stimulation of angiogenesis/oxidative stress reduction/cellular migration/neuroprotection/comprehensive tissue remodeling. Additional potential research applications include longevity studies/hair/skin vitality/systemic recovery after injury/neurological models/regenerative medicine. The multi-pathway nature of KLOW may provide advantage for whole systems wellness investigation.

Other Research Applications & Findings:

Purified Research Grade — > 99% HPLC verified purity for reliable laboratory testing/reproduction.
Multi-Peptide Convenience –> Simplifies protocols requiring separate preparation/administration of multiple compounds.
Multiple Model Systems Suitable For Research –> Orthopedics/sports injury/wound healing/study skin/Dermatology/anti-aging/longevity/recovery/performance regeneration/whole body recovery models.
Lyophilized Powder Stability/Compounds –> Designed for stability in research environments when properly stored/reconstituted.

Why Researchers Prefer KLOW

Researchers prefer KLOW because it allows them to avoid preparing individual peptides separately; thus providing consistent ratios for experimental replication and utilize known synergisms to potentially generate stronger study outcomes. Furthermore, due to its comprehensive profile, KLOW is a viable option for both detailed mechanistic study and broader regenerative study.

KLOW is for sale exclusively for laboratory research purposes only (in vitro/preclinical). Not intended for human/veterinary consumption/use for diagnosis/thereapeutic purpose. All references regarding human benefit derived from individual peptides; no clinical data exists for the blended formulation. All users are expected to comply with all relevant institutionally established guidelines/local regulations/ethical standards/security policies.